Non-small-cell lung cancer: should histology guide chemotherapy treatment?
作者信息
Bennouna J, Senellart H, Douillard J-Y
机构信息
Department of Medical Oncology, Centre Rene Gauducheau, Nantes, France.
Department of Medical Oncology, Centre Rene Gauducheau, Nantes, France.
出版信息
Ann Oncol. 2009 Sep;20(9):1608-1609. doi: 10.1093/annonc/mdp376. Epub 2009 Jul 24.
PMID:19633043
Abstract
摘要
相似文献
1
Non-small-cell lung cancer: should histology guide chemotherapy treatment?非小细胞肺癌：组织学应指导化疗治疗吗？
Ann Oncol. 2009 Sep;20(9):1608-1609. doi: 10.1093/annonc/mdp376. Epub 2009 Jul 24.
2
Histology-based treatment: a new scenario in the management of advanced nonsmall cell lung cancer.
Curr Opin Oncol. 2009 Mar;21(2):97-8. doi: 10.1097/CCO.0b013e328322ca04.
3
A decade of advances in treatment for advanced non-small cell lung cancer.在治疗晚期非小细胞肺癌方面取得的十年进展。
Clin Chest Med. 2011 Dec;32(4):839-51. doi: 10.1016/j.ccm.2011.08.017.
4
If histology matters..
J Clin Oncol. 2010 Apr 10;28(11):1810-2. doi: 10.1200/JCO.2009.27.1247. Epub 2010 Mar 8.
5
The evolving role of histology in the treatment of non-small cell lung cancer.
Med Health R I. 2010 Oct;93(10):317-9.
6
Efficacy differences of pemetrexed by histology in pretreated patients with stage IIIB/IV non-small cell lung cancer: review of results from an open-label randomized phase II study.预处理的 IIIB/IV 期非小细胞肺癌患者中组织学类型对培美曲塞疗效的影响：一项开放标签随机 II 期研究结果回顾。
J Thorac Oncol. 2009 Dec;4(12):1530-6. doi: 10.1097/JTO.0b013e3181b9e608.
7
[Role of pemetrexed in the treatment of advanced non-small-cell lung cancer: news from ASCO, 2008].培美曲塞在晚期非小细胞肺癌治疗中的作用：2008年美国临床肿瘤学会的消息
Tumori. 2008 Sep-Oct;94(5):suppl 3-13.
8
Sorafenib in patients with advanced non-small cell lung cancer that harbor K-ras mutations: a brief report.索拉非尼用于携带K-ras突变的晚期非小细胞肺癌患者：简要报告
J Thorac Oncol. 2010 May;5(5):719-20. doi: 10.1097/JTO.0b013e3181d86ebf.
9
[Early results of chemotherapy in patients with non-small cell lung cancer].
Pneumonol Alergol Pol. 1996;64(11-12):774-9.
10
First-line gefitinib treatment for patients with advanced non-small cell lung cancer with poor performance status.一线吉非替尼治疗体力状况不佳的晚期非小细胞肺癌患者。
J Thorac Oncol. 2010 Mar;5(3):361-8. doi: 10.1097/JTO.0b013e3181cee1ea.
引用本文的文献
1
Survival by histologic subtype in stage IV nonsmall cell lung cancer based on data from the Surveillance, Epidemiology and End Results Program.根据 Surveillance, Epidemiology and End Results Program 数据库，IV 期非小细胞肺癌的组织学亚型与生存的关系。
Clin Epidemiol. 2011;3:139-48. doi: 10.2147/CLEP.S17191. Epub 2011 Apr 28.
Zotero 插件